Literature DB >> 2844808

Angiotensin II potentiates prostaglandin stimulation of cyclic AMP levels in intact bovine adrenal medulla cells but not adenylate cyclase in permeabilized cells.

M R Boarder1, R Plevin, D B Marriott.   

Abstract

The level of cyclic AMP in primary cultures of bovine adrenal medulla cells is elevated by prostaglandin E1. Angiotensin II is commonly reported to act on receptors linked to phosphoinositide metabolism or to inhibition of adenylate cyclase. We have investigated the effect of angiotensin II on prostaglandin E1-stimulated cyclic AMP levels in these primary cultures. Rather than reducing cyclic AMP levels, we have found that angiotensin II powerfully potentiates prostaglandin E1-stimulated cyclic AMP accumulation in intact cells, both in the presence and absence of phosphodiesterase inhibitors. The 50% maximal response was similar to that for stimulation of phosphoinositide breakdown by angiotensin II in these cultures. The potentiation of stimulated cyclic AMP levels was seen, although to a smaller maximum, with the protein kinase C (Ca2+/phospholipid-dependent enzyme) activating phorbol ester tetradecanoyl phorbolacetate and with the synthetic diacylglycerol 1-oleoyl-2-acetylglycerol; pretreatment (24 h) with active phorbol ester, which would be expected to diminish protein kinase C levels, attenuated the angiotensin II potentiation of cyclic AMP. Using digitonin-permeabilized cells we showed that adenylate cyclase activity was stimulated by prostaglandin E1 with the same dose-response relationship as was cyclic AMP accumulation in intact cells, but the permeabilized cells showed no response to angiotensin II. The results are discussed with respect to the hypothesis that the angiotensin II influence on cyclic AMP levels is mediated, in part, by diacylglycerol stimulation of protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844808

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Receptors and transduction mechanisms in anterior pituitary: primary cultures, transfected clonal cells and human tumor derived cells.

Authors:  A Enjalbert
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

Review 2.  Noncholinergic control of adrenal catecholamine secretion.

Authors:  B G Livett; P D Marley
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

3.  Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells.

Authors:  M K Stachowiak; P A Maher; A Joy; E Mordechai; E K Stachowiak
Journal:  Mol Biol Cell       Date:  1996-08       Impact factor: 4.138

4.  Potentiation of receptor-mediated cAMP production: role in the cross-talk between vasopressin V1a and V2 receptor transduction pathways.

Authors:  C Klingler; N Ancellin; M B Barrault; A Morel; B Corman
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors.

Authors:  H Peng; J Moffett; J Myers; X Fang; E K Stachowiak; P Maher; E Kratz; J Hines; S J Fluharty; E Mizukoshi; D C Bloom; M K Stachowiak
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

6.  Regulation of cyclic AMP by extracellular ATP in cultured brain capillary endothelial cells.

Authors:  Z Anwar; J L Albert; S E Gubby; J P Boyle; J A Roberts; T E Webb; M R Boarder
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

7.  Influence of phorbol esters, and diacylglycerol kinase and lipase inhibitors on noradrenaline release and phosphoinositide hydrolysis in chromaffin cells.

Authors:  J A Jones; P J Owen; M R Boarder
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

8.  Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells.

Authors:  M K Stachowiak; J Moffett; A Joy; E Puchacz; R Florkiewicz; E K Stachowiak
Journal:  J Cell Biol       Date:  1994-10       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.